Company / Capital Expenditures
MIMEDX GROUP, INC. Capital Expenditures History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.0M
FY2023
5-year range
$1.5M / $3.2M
FY2021-FY2023
Trend
+31.2%
vs FY2022
Sector context
#140 of 147
Health Care
What the data says
Among 147 Health Care companies, MIMEDX GROUP, INC. is in the bottom 5% for capital expenditures. Declined from $3M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2023.
Declined from $3M to $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 147This company $2.0M Sector average $266.4M
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2023, capital expenditures increased 31.2% year-over-year.
- Ranks #140 out of 147 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.50 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $2.0M | +31.2% |
| FY2022 | $1.5M | -53.0% |
| FY2021 | $3.2M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026